They used flow cytometry for apoptosis; western blotting for protein levels of hexokinase 2 (HK2), MAGT1, Bcl-2, and BCL2-associated X (Bax) in glioma samples; and CCK8 assay for cell viability. Here, HK2 is linked to central nervous system cancer.